In late June 2019, Vienna hosted the ESHRE 35th Annual Meeting, bringing together over 12,000 global experts. The congress highlighted crucial advancements in laboratory safety, protocol standardization, and eliminating human error risks during gamete and embryo handling.
A central highlight of the commercial exhibition was the global shift toward lab digitization, particularly the evolution of RFID-based electronic witnessing systems (such as RI Witness) engineered to track sample transfers and ensure ultimate mismatch prevention.
The LLC ART MEDICAL LTD delegation focused on analyzing emerging global safety standards while conducting strategic sessions with primary manufacturing partners.
Key Working Priorities:
-
Exploring Innovations in Laboratory Security: Reviewed international best practices regarding automated procedure tracking, digital sample identification, and electronic verification protocols in IVF units;
-
Evaluating Culture & Cryopreservation Media: Analyzed clinical data regarding modern embryo culture media and cryopreservation systems;
-
Two-Way Technical Dialogue with Partner Brands: During dedicated B2B sessions, our team delivered consolidated practical feedback from Ukrainian embryologists, addressing microinstrument ergonomics and precision in routine laboratory protocols;
-
Distribution & Supply Alignment: Reviewed mid-year performance metrics with manufacturing executives and finalized supply targets to guarantee stable inventory for Ukrainian IVF centers.
Participating in ESHRE 2019 in Vienna enabled ART MEDICAL to stay aligned with leading global quality standards, ensuring that Ukrainian embryology units receive top-tier medical devices and consumables from trusted international partners.
We express our gratitude to our international manufacturing partners for constructive dialogue and productive collaboration!